Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation
- PMID: 1467165
- DOI: 10.3109/08880019209016603
Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation
Abstract
The objectives of the study were to compare the efficacy and safety of a continuous infusion (CIV) of morphine and intermittent parenteral opioids (IPO) in children with sickle cell vaso-occlusive crises (VOCs); to determine whether 50% oxygen administration through a face mask can reduce the duration of severe pain in patients receiving CIV morphine; and to measure morphine concentration at steady state for pharmacokinetic and pharmacodynamic analysis in patients receiving CIV morphine. The study was designed as a prospective, controlled, "before-and-after" evaluation of two different analgesic regimens. For patients receiving CIV morphine, there was a randomized, double-blind, placebo-controlled study of O2 vs. air. The patients were 66 children with sickle cell disease, 3-18 years old, requiring opioid therapy for severe VOC (32 patients in phase A, 34 in phase B). The analgesic regimens were as follows: phase A: meperidine, morphine, or codeine IM or IV bolus every 3 or 4 hours; phase B: morphine sulfate, loading dose 0.15 mg followed by CIV 0.04 mg/kg/hr. The infusion rate was adjusted every 8 hours according to pain and/or symptoms of opioid toxicity. Pain assessment was by behavioral observation (BPS). In terms of results, the mean opioid dose (morphine equivalent) was similar in both groups (0.032 +/- 0.020 mg/kg/hr in phase A and 0.035 +/- 0.011 in phase B). However, the duration of severe pain was significantly shorter in phase B (0.9 +/- 1.0 days) than in phase A (2.0 +/- 1.8 days). No severe opioid toxicity was observed in either group. Oxygen did not shorten the duration of severe pain compared to the placebo group (0.94 +/- 1.08 and 0.95 +/- 1.19 days, respectively) nor did it prevent the appearance of new pain sites. Pharmacokinetic analysis was performed in 24 patients of phase B. Total body clearance (TBC) of morphine was greater in children before puberty than after (40.4 +/- 10 vs. 28 +/- 11 mL/kg/min; p < 0.05). In conclusion, in children with severe VOCs, continuous infusion of morphine provides better analgesia than intermittent opioid therapy. Fifty percent oxygen inhalation had no effect on the duration of pain.
Similar articles
-
Pilot study of continuous co-infusion of morphine and naloxone in children with sickle cell pain crisis.Am J Hematol. 2008 Sep;83(9):728-31. doi: 10.1002/ajh.21213. Am J Hematol. 2008. PMID: 18543345 Free PMC article. Clinical Trial.
-
Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone.J Pediatr. 1996 Nov;129(5):722-8. doi: 10.1016/s0022-3476(96)70156-7. J Pediatr. 1996. PMID: 8917240 Clinical Trial.
-
Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.Scand J Pain. 2018 Jan 26;18(1):19-27. doi: 10.1515/sjpain-2017-0140. Scand J Pain. 2018. PMID: 29794277 Clinical Trial.
-
[Pain crises in patients with sickle cell diseases. Pathogenesis, clinical aspects, therapy].Klin Padiatr. 1995 Nov-Dec;207(6):321-5. doi: 10.1055/s-2008-1046561. Klin Padiatr. 1995. PMID: 8569133 Review. German.
-
Morphine/naltrexone.CNS Drugs. 2010 Jun;24(6):527-38. doi: 10.2165/11204620-000000000-00000. CNS Drugs. 2010. PMID: 20443648 Review.
Cited by
-
Prediction of morphine clearance in the paediatric population : how accurate are the available pharmacokinetic models?Clin Pharmacokinet. 2012 Nov;51(11):695-709. doi: 10.1007/s40262-012-0006-9. Clin Pharmacokinet. 2012. PMID: 23018467 Review.
-
Inter-individual variation in morphine clearance in children.Eur J Clin Pharmacol. 2015 Jun;71(6):649-655. doi: 10.1007/s00228-015-1843-x. Epub 2015 Apr 8. Eur J Clin Pharmacol. 2015. PMID: 25845657 Free PMC article.
-
Sickle cell disease.BMJ Clin Evid. 2011 Feb 14;2011:2402. BMJ Clin Evid. 2011. PMID: 21718552 Free PMC article.
-
Pain management in children with sickle cell disease.Paediatr Drugs. 2003;5(4):229-41. doi: 10.2165/00128072-200305040-00003. Paediatr Drugs. 2003. PMID: 12662119 Review.
-
Guidelines on neonatal screening and painful vaso-occlusive crisis in sickle cell disease: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: Project guidelines: Associação Médica Brasileira - 2016.Rev Bras Hematol Hemoter. 2016 Apr-Jun;38(2):147-57. doi: 10.1016/j.bjhh.2016.04.001. Epub 2016 Apr 8. Rev Bras Hematol Hemoter. 2016. PMID: 27208574 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical